BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for December 24, 2024

Dec. 24, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x, Allurion, Avero, Bruker, Fuse-AI, Personalis, Pineapple Power, Prescient Medical, Merck, Moderna, Myr, Northwest Pathology, Signati, Solvd, Spectral AI, Statlab, Trinity Biotech, Versant, Vivos, Xlife.
Read More

Other news to note for December 24, 2024

Dec. 24, 2024
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Aadi, Certa, Corxel, Cytokinetics, Hangzhou Dac, Henlius, HLB Innovation, Inceptor, Lanova, Merck, Palleon, Racthera, Sumitomo Chemical, Verismo, Wuxi.
Read More

Other news to note for Dec. 23, 2024

Dec. 23, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aadi, Aridis, Corxel, Cytokinetics, Dac Bio, Epitopea, Eton, Genevant, HLB Innovation, Idordia, Ipsen, Merck, Pyxis, Sanofi, Verismo, Wuxi Biologics.
Read More

Other news to note for December 23, 2024

Dec. 23, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axena, Eisai, Flomics, Fujirebio, H.U. Group, Lucid, Oncodia, Renavaro, Roivios, Singular Genomics.
Read More

Other news to note for Dec. 20, 2024

Dec. 20, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abilita, Certa, Deepcure, Henlius, NGM, Palleon, Orion, Occurx.
Read More

Other news to note for December 20, 2024

Dec. 20, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Commure, Memora Health, Modular Medical, Orasure Technologies, Orthalign, Sherlock Biosciences.
Read More

Other news to note for Dec. 20, 2024

Dec. 20, 2024
Additional early-stage research and drug discovery news in brief, from: Ascletis Pharma, NMD Pharma, Pila Pharma.
Read More

Other news to note for Dec. 19, 2024

Dec. 19, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cara, Clarity, Catalent, Eli Lilly, Grit, Holoclara, Inceptor, Novo Nordisk, Photys, Structure, Tvardi, Ultimovacs, Zelluna.
Read More

Other news to note for December 19, 2024

Dec. 19, 2024
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 908 Devices, Andromeda Surgical, Bio-Techne, Bivacor, Bridge to Life, Brij, Cardiofocus, Getinge, Lucid, Medica, Medline, MGI Tech, Pavmed, Sabin, Vitalexam, Waters.
Read More

Other news to note for Dec. 18, 2024

Dec. 18, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abera, Atara, Bionomics, Evonik, Gilead, Hub Organoids, Immunova, Iox, Merck, Milliporesigma, Neuphoria, Orexo, Portage, Racthera, Silexion, Sumitomo Chemical, Sumitomo Pharma, Terray.
Read More
Previous 1 2 … 71 72 73 74 75 76 77 78 79 … 1396 1397 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 7, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing